| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 304.70M | 275.30M | 277.10M | 279.00M | 234.30M |
| Gross Profit | 84.60M | 122.50M | 116.40M | 81.90M | 68.50M |
| EBITDA | 71.30M | 77.70M | 30.00M | 75.90M | 69.50M |
| Net Income | 1.30M | 12.40M | -30.70M | 16.80M | 11.50M |
Balance Sheet | |||||
| Total Assets | 587.20M | 553.70M | 549.40M | 615.20M | 605.60M |
| Cash, Cash Equivalents and Short-Term Investments | 3.40M | 8.00M | 22.70M | 30.20M | 32.90M |
| Total Debt | 260.10M | 237.00M | 224.00M | 248.60M | 250.70M |
| Total Liabilities | 367.50M | 319.90M | 317.30M | 342.00M | 340.40M |
| Stockholders Equity | 219.70M | 233.80M | 232.10M | 273.20M | 265.20M |
Cash Flow | |||||
| Free Cash Flow | 40.00M | 42.80M | 37.50M | 36.80M | 38.90M |
| Operating Cash Flow | 53.20M | 58.50M | 47.80M | 47.80M | 47.70M |
| Investing Cash Flow | -45.80M | -15.60M | -12.00M | -22.50M | -95.50M |
| Financing Cash Flow | -10.90M | -60.80M | -43.30M | -28.00M | 54.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £2.13B | 13.52 | 20.41% | 2.58% | 11.42% | -17.18% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £482.06M | 14.60 | 13.04% | 3.18% | 6.55% | 18.44% | |
60 Neutral | £282.83M | -0.96 | -12.22% | 15.28% | -3.91% | -310.36% | |
54 Neutral | £330.14M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% | |
42 Neutral | £1.70B | 170.75 | ― | 0.36% | -2.24% | ― | |
41 Neutral | £318.50M | -2.81 | -142.88% | ― | -4.87% | ― |